Literature DB >> 3363963

Prevalence of hepatitis delta (delta) virus infection. A seroepidemiologic study.

K M DeCock, B Jones, S Govindarajan, A G Redeker.   

Abstract

In assessing the prevalence of hepatitis delta (delta) virus (HDV) infection in 358 patients with acute hepatitis B seen in Los Angeles between 1983 and 1985 and in 196 patients with chronic hepatitis B followed between 1980 and 1985, we found that 23% of patients with chronic and 5% of patients with acute hepatitis B were infected with HDV. Among patients with chronic hepatitis B, the prevalence of HDV infection was 73% in intravenous drug users and 14% in homosexual men. Acute coinfection with the hepatitis B virus was also more frequent in drug users (8%) than in other groups. delta-Hepatitis is a common infection in hepatitis B virus carriers in Los Angeles, particularly in drug addicts, but also in homosexual men who do not abuse drugs intravenously.

Entities:  

Mesh:

Year:  1988        PMID: 3363963      PMCID: PMC1026096     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  16 in total

1.  The delta hepatitis agent: "viral hepatitis, type D".

Authors:  I M Jacobson; J L Dienstag
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

2.  The delta agent.

Authors:  M Rizzetto
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

3.  Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.

Authors:  M Rizzetto; J W Shih; D J Gocke; R H Purcell; G Verme; J L Gerin
Journal:  Lancet       Date:  1979-11-10       Impact factor: 79.321

4.  Influence of delta infection on severity of hepatitis B.

Authors:  A Smedile; P Farci; G Verme; F Caredda; A Cargnel; N Caporaso; P Dentico; C Trepo; P Opolon; A Gimson; D Vergani; R Williams; M Rizzetto
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

5.  Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis.

Authors:  S Govindarajan; G C Kanel; R L Peters
Journal:  Gastroenterology       Date:  1983-07       Impact factor: 22.682

6.  Fulminant B viral hepatitis: role of delta agent.

Authors:  S Govindarajan; K P Chin; A G Redeker; R L Peters
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

7.  Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus.

Authors:  A Ponzetto; L B Seeff; Z Buskell-Bales; K G Ishak; J H Hoofnagle; H J Zimmerman; R H Purcell; J L Gerin
Journal:  Hepatology       Date:  1984 Nov-Dec       Impact factor: 17.425

8.  Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen:" clinical significance in delta infection.

Authors:  A Smedile; C Lavarini; O Crivelli; G Raimondo; M Fassone; M Rizzetto
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

9.  Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment.

Authors:  M Rizzetto; G Verme; S Recchia; F Bonino; P Farci; S Aricò; R Calzia; A Picciotto; M Colombo; H Popper
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

10.  Evaluation of anti-HBc IgM estimation by radioimmunoassay for anti-HBc on column separated IgM.

Authors:  K M De Cock; M Ashcavai; S Govindarajan; A G Redeker
Journal:  Ann Clin Lab Sci       Date:  1987 Jan-Feb       Impact factor: 1.256

View more
  6 in total

1.  Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study.

Authors:  Paula J Lum; Kristen C Ochoa; Judith A Hahn; Kimberly Page Shafer; Jennifer L Evans; Andrew R Moss
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

2.  Estimation of the secondary attack rate for delta hepatitis coinfection among injection drug users.

Authors:  C Poulin; T Gyorkos; L Joseph
Journal:  Can J Infect Dis       Date:  1993-01

3.  Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.

Authors:  H Hagan; D C Jarlais; S R Friedman; D Purchase; M J Alter
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

Review 4.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

5.  Delta hepatitis in Denver.

Authors:  W G Rector; S Govindarajan; K A Penley; F N Judson
Journal:  West J Med       Date:  1988-07

6.  High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California.

Authors:  Tse-Ling Fong; Naranbaatar D Dashdorj; Takeshi Saito; Brian T Lee; Mimi Chang; Khishigsuren Nasanbayar; Enkhjargal Tsogtoo; Delgerbat Boldbaatar; Esugen D Dashdorj; Namuun E Clifford; Arghun N Dashdorj; Bo-Ram Bang; Takeshi Chida; Carolina Lim; Masaya Sugiyama; Masashi Mizokami; Naranjargal J Dashdorj; Ping Liu; Jeffrey S Glenn
Journal:  Dig Dis Sci       Date:  2020-08-08       Impact factor: 3.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.